FDA approval for Emrosi (minocycline hydrochloride) extended release capsule to treat rosacea – Journey Medical
Journey Medical Corporation announced that the FDA has approved Emrosi(minocycline hydrochloride extended release capsules, 40 mg), formerly referred to as DFD-29, for the treatment of inflammatory lesions of… read more.
